Chemical Compound
( inverted exclamation markA)-cis-2-Methylspiro[1,3-oxathiolane-5,3 inverted exclamation marka-quinuclidine]; Spiro[1-azabicyclo[2.2.2]octane-3,5 inverted exclamation marka-[1,3]oxathiolane], 2 inverted exclamation marka-methyl-, (2 inverted exclamation markaR,3R)-rel-
CAS Registry Number
107233-08-9
Primary record
( inverted exclamation markA)-cis-2-Methylspiro[1,3-oxathiolane-5,3 inverted exclamation marka-quinuclidine]; Spiro[1-azabicyclo[2.2.2]octane-3,5 inverted exclamation marka-[1,3]oxathiolane], 2 inverted exclamation marka-methyl-, (2 inverted exclamation markaR,3R)-rel-
- 库存
- 4,050 克
- 纯度
- 98.9 %
- CAS
- 107233-08-9
化合物标识与属性
- CAS
- 107233-08-9
- PubChem CID
- 83898
- SMILES
- C[C@@H]1O[C@]2(CN3CCC2CC3)CS1
- Canonical SMILES
- C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1
名称与同义词
- Cevimeline
- Evoxac
- Saligren
- Cevimeline HCl
- Cevimeline [INN]
- Cevimeline (INN)
- Cevimeline Sulfoxide
- Cevimeline hydrochloride
- 107233-08-9
- Fks 508
- C10H17NOS
- cevimeline trans-sulfoxide
- Sni 2011
- UNII-K9V0CDQ56E
- AC1L36EF
- HSDB 7286
- BIDD:GT0265
- SCHEMBL188381
- SCHEMBL223163
- AF-102B
- cevimeline hydrochloride hydrate
- AF102B
- orb1705229
- CHEMBL1201267
- DTXSID2023777
- CTK8E6849
- ZINC10163
- AF 102B
- FKS-508
- WUTYZMFRCNBCHQ-PSASIEDQSA-N
- DTXSID401338115
- C10-H17-N-O-S
- Cevimeline hydrochloride hemihydrate
- CID83898
- KS-00000XL8
- SNI-2011
- EBC-71033
- MFCD22577792
- AKOS025294043
- CB11424
- CS-0397
- EBC-375043
- (-)-Cevimeline hydrochloride hemihydrate
- (-)-SNI-2011
- AN-33787
- AS-56166
- HY-70020
- 2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine
- J221.668J
- LS-172037
- RT-011982
- A3299
- NS00068154
- X7254
- D07667
- EN300-814007
- G79234
- W-5959
- 1035535-90-0
- N0001-022908
- (+-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine]
- (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine]
- cis-2-Methyl-1'-azaspiro[[1,3]oxathiolane-5,3'-bicyclo[2.2.2]octane]
- (2R,5'R)-5'-methyl-4-azaspiro[bicyclo[2.2.2]octane-2,2'-[1,4]oxathiolane]
- (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]
- (2a(2)R,3R)-2a(2)-Methylspiro[1-azabicyclo[2.2.2]octane-3,5a(2)-[1,3]oxathiolane]
- (2R,2'R)-2'-methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane]
- (2R,3'R)-2-Methyl-1'-azaspiro[[1,3]oxathiolane-5,3'-bicyclo[2.2.2]octane]
- (3R,2 R)-2 -Methylspiro[1-azabicyclo[2.2.2]octane-3,5 -[1,3]oxathiolane]
- Spiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)-oxathiolane), 2'-methyl-, (2'R,3R)-rel-
- Spiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)-oxathiolane), 2'-methyl-, cis-
- ( inverted exclamation markA)-cis-2-Methylspiro[1,3-oxathiolane-5,3 inverted exclamation marka-quinuclidine]; Spiro[1-azabicyclo[2.2.2]octane-3,5 inverted exclamation marka-[1,3]oxathiolane], 2 inverted exclamation marka-methyl-, (2 inverted exclamation markaR,3R)-rel-
- 124751-36-6